Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel EtG-Based Contingency Management for Alcohol in the Severely Mentally Ill

NCT03481049 is registered in ClinicalTrials.gov with Washington State University as lead sponsor.

NCT NCT03481049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03481049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel EtG-Based Contingency Management for Alcohol in the Severely Mentally Ill
Lead sponsor
Washington State University
Phase
Not applicable
Overall status
Completed
Start date
May 5, 2018
Completion date
November 22, 2024
Enrollment
392 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence, bipolar disorder, major depressive disorder, schizophrenia